Work

Supplementary Figure 2 from Targeting IGF-IR with Ganitumab Inhibits Tumorigenesis and Increases Durability of Response to Androgen-Deprivation Therapy in VCaP Prostate Cancer Xenografts

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 151K, Evaluation of AR and ARΔLBD in androgen-dependent VCaP xenografts, castration-resistant VCaP xenografts, and castration-resistant 22Rv1 xenografts

DOI: 10.1158/1535-7163.22497697.v1

Authors: Cale D. Fahrenholtz, Pedro J. Beltran, Kerry L. Burnstein

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362478696

Cites:

Cited by:

Related to: 10